Dr. Joel Lardizabal, MD
835 Aerovista Pl, San Luis Obispo, CA 93401 • +1-651-555-7586
Medical Education: Accredited U.S. Medical School (Class of 2013)
What This Doctor Actually Performs: CMS Medicare Utilization & San Luis Obispo Percentiles
NPI #1508960527 • CBSA Regional • Interventional Cardiology
CMS Medicare Part B utilization records credit Dr. Joel Lardizabal (MD, NPI 1508960527) at 835 Aerovista Pl in San Luis Obispo with 5,622 annual clinical services (1,487 beneficiaries), corresponding to a +0.29σ regional deviation and mid-cohort balanced caseload (60th San Luis Obispo percentile) with sub-specialty concentration in 75 Active CMS HCPCS Codes.
Procedural volume for Dr. Lardizabal is led by HCPCS 99214 (Moderate-to-High Complexity Internal Medicine Follow-Up — 2451 annual services, $179–$246 GPCI cash estimate), followed by CPT 99213 (Established Preventive & Chronic Care Visit, 1416/yr) and CPT 93000 (In-Office 12-Lead Resting Electrocardiogram, 708/yr).
At 835 Aerovista Pl (93401), Dr. Joel Lardizabal, MD accommodates direct self-pay scheduling (in-person clinic visits only) at ~$239.00 per new consult (4.58/5 bedside rating).
Credentialed as an MD specialist with 13 years post-graduation experience since completing medical school at an LCME/COCA institution (2013), Dr. Lardizabal coordinates 75 Active CMS HCPCS Codes workups from 835 Aerovista Pl (+1-651-555-7586).
Compared against San Luis Obispo, CA Interventional Cardiology peers
5,622 annual services across 1,487 beneficiaries
Standard deviations from CA Interventional Cardiology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 2,451 | 60th | $179 – $246 |
| 99213 | Established Preventive & Chronic Care Visit | 1,416 | 60th | $137 – $188 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 708 | 65th | $65 – $90 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 545 | 57th | $210 – $288 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 327 | 64th | $249 – $342 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (75 HCPCS billing breadth) | 176 | 60th | $162 – $235 |
Are you Dr. Joel Lardizabal? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in San Luis Obispo, CA:
<a href="https://dotmd.com/doctors/joel-lardizabal-md-san-luis-obispo-ca-1508960527" title="Dr. Joel Lardizabal, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1508960527.svg" alt="Dr. Joel Lardizabal Interventional Cardiology Badge" width="280" height="72" /></a>
Dr. Joel Lardizabal, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Lardizabal National Provider Identifier | NPI #1508960527 (MD) | CMS NPPES Registry (93401) |
| Dr. Lardizabal San Luis Obispo CMS Volume Rank | 60.00th Pct (5,622 CMS svcs; Z +0.294σ) | CMS Medicare Part B (CA Interventional Cardiology) |
| Fair Cash-Pay New-Patient Benchmark | $239.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (San Luis Obispo, CA) |
| Waiting-Room Wait Time & Cash Friendliness | $239.00 avg paid • 11 min lobby wait | 9 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.58/5 Listening • 4.93/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Joel Lardizabal
Other High-Volume Interventional Cardiology Specialists in San Luis Obispo, CA
Ranked strictly by CMS Medicare volumeDr. Lardizabal Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in San Luis Obispo, CA.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Joel Lardizabal community threads and patient logs by age, biological sex, dosage, and treatment duration.